Managed by Sanofi • Latest filing Q4 2025
Overlap peers will appear here as data populates
Related fund suggestions coming soon.
| $79.5M |
| 12.20M |
| 0.00% |
| — |
| 6 | M MGTX — | $74.3M | 12.20M | 0.00% | — |
| 7 | N NVAX — | $59.7M | 6.88M | 0.00% | — |
| 8 | N NVAX — | $55.3M | 6.88M | 0.00% | — |
| 9 | N NVAX — | $46.2M | 6.88M | 0.00% | — |
| 10 | N NVAX — | $44.1M | 6.88M | 0.00% | — |
| 11 | N NVAX — | $43.3M | 6.88M | 0.00% | — |
| 12 | A | $39.8M | 821.9K | 0.00% | — |
| 13 | I INBX — | $39M | 1.16M | 0.00% | — |
| 14 | A | $25.2M | 821.9K | 0.00% | — |
| 15 | I IMRX — | $19M | 2.71M | 0.00% | — |
| 16 | A | $18.2M | 821.9K | 0.00% | — |
| 17 | I INBX — | $17.8M | 1.16M | 0.00% | — |
| 18 | I IMRX — | $17.8M | 2.71M | 0.00% | — |
| 19 | I INBX — | $16.5M | 1.16M | 0.00% | — |
| 20 | I INBX — | $16.2M | 1.16M | 0.00% | — |
—